Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Wasnich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 10, 2002
Relationship between phalangeal bone density and risk of vertebral fractureMisako Ohtsuka, Daniel Michaeli, Richard D Wasnich
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 5, 2002
What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?Neil C Binkley, Peg Schmeer, Richard D Wasnich, et al.
Bone|November 16, 2004
Letter to the editorMarc C Hochberg, Paul D Miller, Richard D Wasnich, et al.
Current Medical Research and Opinion|May 19, 2005
How useful are measures of BMD and bone turnover?Paul D Miller, Marc C Hochberg, Lois E Wehren, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agentsMarc C Hochberg, Susan Greenspan, Richard D Wasnich, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 3, 2004
Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosisMichael R McClung, Richard D Wasnich, Robert Recker, et al.
Journal of Pharmaceutical Sciences|September 15, 2007
Use of accelerator mass spectrometry to measure the pharmacokinetics and peripheral blood mononuclear cell concentrations of zidovudineLe T Vuong, Jon L Ruckle, Arlin B Blood, et al.
Journal of Pain and Symptom Management|August 4, 2010
Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studiesSalman Masud, Richard D Wasnich, Jon L Ruckle, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort StudyMichael R McClung, Richard D Wasnich, David J Hosking, et al.
Current Medical Research and Opinion|April 7, 2005
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONECharles H Chesnut, Mark P Ettinger, Paul D Miller, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 10, 2002
Relationship between phalangeal bone density and risk of vertebral fractureMisako Ohtsuka, Daniel Michaeli, Richard D Wasnich
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 5, 2002
What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?Neil C Binkley, Peg Schmeer, Richard D Wasnich, et al.
Bone|November 16, 2004
Letter to the editorMarc C Hochberg, Paul D Miller, Richard D Wasnich, et al.
Current Medical Research and Opinion|May 19, 2005
How useful are measures of BMD and bone turnover?Paul D Miller, Marc C Hochberg, Lois E Wehren, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agentsMarc C Hochberg, Susan Greenspan, Richard D Wasnich, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 3, 2004
Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosisMichael R McClung, Richard D Wasnich, Robert Recker, et al.
Journal of Pharmaceutical Sciences|September 15, 2007
Use of accelerator mass spectrometry to measure the pharmacokinetics and peripheral blood mononuclear cell concentrations of zidovudineLe T Vuong, Jon L Ruckle, Arlin B Blood, et al.
Journal of Pain and Symptom Management|August 4, 2010
Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studiesSalman Masud, Richard D Wasnich, Jon L Ruckle, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort StudyMichael R McClung, Richard D Wasnich, David J Hosking, et al.
Current Medical Research and Opinion|April 7, 2005
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONECharles H Chesnut, Mark P Ettinger, Paul D Miller, et al.
Pageof 2